- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Novel Agents in the Treatment of R/R CLL
41 views
October 9, 2024
Chapters
Decade of CLL Target Therapy & Recent Approvals
00:00
Treatment Sequencing Scenarios in CLL
01:38
Transition from Ibrutinib to Second-Gen BTK Inhibitors
03:54
Pirtobrutinib Approval & Resistance Challenges
05:51
CAR-T Liso-cel Approval & PFS Analysis
10:21
Emerging CLL Therapies & BTK Degraders
12:17
Comments 0
Login to view comments.
Click here to Login
Leukemia